Risk for Autoimmune Inflammatory Rheumatic Disease Increased After SARS-CoV-2
TUESDAY, March 5, 2024 -- Patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have an increased risk for incident autoimmune inflammatory rheumatic disease (AIRD) compared with matched patients with influenza...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Autoimmune Disease | Coronavirus | COVID-19 | Influenza | Pharmaceuticals | Respiratory Medicine | Rheumatology | SARS